| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.0002 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |